×

Human Genome Rejects GlaxoSmithKline's Bid

12:41 PM ET Thu, 19 April 2012

Human Genome Sciences rejected the $2.6 billion unsolicited takeover bid from GlaxoSmithKline, reports CNBC's Herb Greenberg.